TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.

Céline Boutry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.